Specialty Business Services
Compare Stocks
5 / 10Stock Comparison
DLHC vs CRAI vs ICFI vs LDOS vs SAIC
Revenue, margins, valuation, and 5-year total return — side by side.
Consulting Services
Consulting Services
Information Technology Services
Information Technology Services
DLHC vs CRAI vs ICFI vs LDOS vs SAIC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Business Services | Consulting Services | Consulting Services | Information Technology Services | Information Technology Services |
| Market Cap | $83M | $899M | $1.35B | $16.51B | $4.24B |
| Revenue (TTM) | $293M | $771M | $1.82B | $17.48B | $7.26B |
| Net Income (TTM) | $-4M | $48M | $85M | $1.36B | $358M |
| Gross Margin | 14.4% | 20.3% | 27.2% | 17.3% | 12.0% |
| Operating Margin | 2.5% | 9.8% | 7.9% | 11.6% | 7.1% |
| Forward P/E | 60.8x | 16.9x | 10.6x | 11.1x | 9.3x |
| Total Debt | $145M | $127M | $571M | $5.93B | $217M |
| Cash & Equiv. | $125K | $18M | $5M | $1.20B | $182M |
DLHC vs CRAI vs ICFI vs LDOS vs SAIC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| DLH Holdings Corp. (DLHC) | 100 | 77.4 | -22.6% |
| CRA International, … (CRAI) | 100 | 344.4 | +244.4% |
| ICF International, … (ICFI) | 100 | 113.6 | +13.6% |
| Leidos Holdings, In… (LDOS) | 100 | 124.6 | +24.6% |
| Science Application… (SAIC) | 100 | 106.9 | +6.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DLHC vs CRAI vs ICFI vs LDOS vs SAIC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DLHC ranks third and is worth considering specifically for momentum.
- +41.5% vs SAIC's -20.9%
CRAI is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 9.3%, EPS growth 20.8%, 3Y rev CAGR 8.3%
- 5.5% 10Y total return vs LDOS's 223.8%
- 9.3% revenue growth vs DLHC's -13.0%
- 1.5% yield, 9-year raise streak, vs SAIC's 1.6%, (1 stock pays no dividend)
Among these 5 stocks, ICFI doesn't own a clear edge in any measured category.
LDOS carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 0.54 vs ICFI's 0.92
- PEG 0.54 vs 0.92
- 7.8% margin vs DLHC's -1.5%
- 9.4% ROA vs DLHC's -1.6%, ROIC 17.1% vs 4.7%
SAIC is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 0.26, yield 1.6%
- Lower volatility, beta 0.26, Low D/E 14.5%, current ratio 1.20x
- Beta 0.26, yield 1.6%, current ratio 1.20x
- Beta 0.26 vs DLHC's 0.82, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.3% revenue growth vs DLHC's -13.0% | |
| Value | PEG 0.54 vs 0.92 | |
| Quality / Margins | 7.8% margin vs DLHC's -1.5% | |
| Stability / Safety | Beta 0.26 vs DLHC's 0.82, lower leverage | |
| Dividends | 1.5% yield, 9-year raise streak, vs SAIC's 1.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | +41.5% vs SAIC's -20.9% | |
| Efficiency (ROA) | 9.4% ROA vs DLHC's -1.6%, ROIC 17.1% vs 4.7% |
DLHC vs CRAI vs ICFI vs LDOS vs SAIC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DLHC vs CRAI vs ICFI vs LDOS vs SAIC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LDOS leads in 1 of 6 categories
DLHC leads 1 • CRAI leads 1 • SAIC leads 1 • ICFI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LDOS leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LDOS is the larger business by revenue, generating $17.5B annually — 59.7x DLHC's $293M. LDOS is the more profitable business, keeping 7.8% of every revenue dollar as net income compared to DLHC's -1.5%. On growth, CRAI holds the edge at +10.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $293M | $771M | $1.8B | $17.5B | $7.3B |
| EBITDAEarnings before interest/tax | $25M | $98M | $201M | $2.2B | $666M |
| Net IncomeAfter-tax profit | -$4M | $48M | $85M | $1.4B | $358M |
| Free Cash FlowCash after capex | $19M | -$17M | $151M | $1.7B | $609M |
| Gross MarginGross profit ÷ Revenue | +14.4% | +20.3% | +27.2% | +17.3% | +12.0% |
| Operating MarginEBIT ÷ Revenue | +2.5% | +9.8% | +7.9% | +11.6% | +7.1% |
| Net MarginNet income ÷ Revenue | -1.5% | +6.2% | +4.7% | +7.8% | +4.9% |
| FCF MarginFCF ÷ Revenue | +6.5% | -2.2% | +8.3% | +9.6% | +8.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -33.6% | +10.5% | -10.3% | +3.7% | -4.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -4.0% | -35.5% | -22.2% | -7.6% | -6.5% |
Valuation Metrics
DLHC leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 11.8x trailing earnings, LDOS trades at a 81% valuation discount to DLHC's 60.8x P/E. Adjusting for growth (PEG ratio), LDOS offers better value at 0.57x vs ICFI's 1.31x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $83M | $899M | $1.3B | $16.5B | $4.2B |
| Enterprise ValueMkt cap + debt − cash | $228M | $1.0B | $1.9B | $21.2B | $4.3B |
| Trailing P/EPrice ÷ TTM EPS | 60.83x | 17.09x | 15.05x | 11.79x | 12.22x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.88x | 10.60x | 11.08x | 9.33x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.79x | 1.31x | 0.57x | 0.73x |
| EV / EBITDAEnterprise value multiple | 6.71x | 10.36x | 9.13x | 8.82x | 6.43x |
| Price / SalesMarket cap ÷ Revenue | 0.24x | 1.20x | 0.72x | 0.96x | 0.58x |
| Price / BookPrice ÷ Book value/share | 0.73x | 4.37x | 1.33x | 3.50x | 2.92x |
| Price / FCFMarket cap ÷ FCF | 3.61x | 48.45x | 11.22x | 10.16x | 7.34x |
Profitability & Efficiency
CRAI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
LDOS delivers a 27.1% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $-4 for DLHC. SAIC carries lower financial leverage with a 0.14x debt-to-equity ratio, signaling a more conservative balance sheet compared to DLHC's 1.28x. On the Piotroski fundamental quality scale (0–9), LDOS scores 8/9 vs CRAI's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.0% | +23.6% | +8.3% | +27.1% | +23.7% |
| ROA (TTM)Return on assets | -1.6% | +7.6% | +4.1% | +9.4% | +6.8% |
| ROICReturn on invested capital | +4.7% | +20.4% | +7.2% | +17.1% | +14.2% |
| ROCEReturn on capital employed | +6.6% | +26.9% | +9.3% | +21.0% | +12.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 6 | 8 | 7 |
| Debt / EquityFinancial leverage | 1.28x | 0.60x | 0.56x | 1.19x | 0.14x |
| Net DebtTotal debt minus cash | $145M | $109M | $566M | $4.7B | $35M |
| Cash & Equiv.Liquid assets | $125,000 | $18M | $5M | $1.2B | $182M |
| Total DebtShort + long-term debt | $145M | $127M | $571M | $5.9B | $217M |
| Interest CoverageEBIT ÷ Interest expense | 0.46x | 14.51x | 6.75x | 9.91x | 3.99x |
Total Returns (Dividends Reinvested)
Evenly matched — DLHC and CRAI and LDOS each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CRAI five years ago would be worth $17,152 today (with dividends reinvested), compared to $5,601 for DLHC. Over the past 12 months, DLHC leads with a +41.5% total return vs SAIC's -20.9%. The 3-year compound annual growth rate (CAGR) favors LDOS at 19.8% vs DLHC's -17.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +2.7% | -30.3% | -12.5% | -28.2% | -6.3% |
| 1-Year ReturnPast 12 months | +41.5% | -20.7% | -11.0% | -14.1% | -20.9% |
| 3-Year ReturnCumulative with dividends | -44.1% | +54.1% | -32.1% | +71.9% | -0.8% |
| 5-Year ReturnCumulative with dividends | -44.0% | +71.5% | -16.9% | +33.4% | +12.4% |
| 10-Year ReturnCumulative with dividends | +24.0% | +550.5% | +100.5% | +223.8% | +104.4% |
| CAGR (3Y)Annualised 3-year return | -17.6% | +15.5% | -12.1% | +19.8% | -0.3% |
Risk & Volatility
SAIC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SAIC is the less volatile stock with a 0.26 beta — it tends to amplify market swings less than DLHC's 0.82 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SAIC currently trades 75.8% from its 52-week high vs CRAI's 61.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.82x | 0.73x | 0.52x | 0.42x | 0.26x |
| 52-Week HighHighest price in past year | $8.10 | $227.29 | $101.71 | $205.77 | $124.11 |
| 52-Week LowLowest price in past year | $3.95 | $135.95 | $64.52 | $129.35 | $81.08 |
| % of 52W HighCurrent price vs 52-week peak | +70.7% | +61.2% | +73.2% | +63.8% | +75.8% |
| RSI (14)Momentum oscillator 0–100 | 45.4 | 41.1 | 59.8 | 24.5 | 46.3 |
| Avg Volume (50D)Average daily shares traded | 8K | 187K | 349K | 1.0M | 563K |
Analyst Outlook
Evenly matched — CRAI and SAIC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CRAI as "Buy", ICFI as "Buy", LDOS as "Buy", SAIC as "Hold". Consensus price targets imply 55.5% upside for LDOS (target: $204) vs 3.6% for SAIC (target: $98). For income investors, SAIC offers the higher dividend yield at 1.60% vs ICFI's 0.75%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $194.00 | $102.50 | $204.00 | $97.50 |
| # AnalystsCovering analysts | — | 1 | 13 | 27 | 18 |
| Dividend YieldAnnual dividend ÷ price | — | +1.5% | +0.8% | +1.2% | +1.6% |
| Dividend StreakConsecutive years of raises | 1 | 9 | 8 | 5 | 2 |
| Dividend / ShareAnnual DPS | — | $2.06 | $0.56 | $1.59 | $1.51 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +5.2% | +4.1% | +5.7% | +10.5% |
LDOS leads in 1 of 6 categories (Income & Cash Flow). DLHC leads in 1 (Valuation Metrics). 2 tied.
DLHC vs CRAI vs ICFI vs LDOS vs SAIC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DLHC or CRAI or ICFI or LDOS or SAIC a better buy right now?
For growth investors, CRA International, Inc.
(CRAI) is the stronger pick with 9. 3% revenue growth year-over-year, versus -13. 0% for DLH Holdings Corp. (DLHC). Leidos Holdings, Inc. (LDOS) offers the better valuation at 11. 8x trailing P/E (11. 1x forward), making it the more compelling value choice. Analysts rate CRA International, Inc. (CRAI) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DLHC or CRAI or ICFI or LDOS or SAIC?
On trailing P/E, Leidos Holdings, Inc.
(LDOS) is the cheapest at 11. 8x versus DLH Holdings Corp. at 60. 8x. On forward P/E, Science Applications International Corporation is actually cheaper at 9. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Leidos Holdings, Inc. wins at 0. 54x versus ICF International, Inc. 's 0. 92x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — DLHC or CRAI or ICFI or LDOS or SAIC?
Over the past 5 years, CRA International, Inc.
(CRAI) delivered a total return of +71. 5%, compared to -44. 0% for DLH Holdings Corp. (DLHC). Over 10 years, the gap is even starker: CRAI returned +550. 5% versus DLHC's +24. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DLHC or CRAI or ICFI or LDOS or SAIC?
By beta (market sensitivity over 5 years), Science Applications International Corporation (SAIC) is the lower-risk stock at 0.
26β versus DLH Holdings Corp. 's 0. 82β — meaning DLHC is approximately 211% more volatile than SAIC relative to the S&P 500. On balance sheet safety, Science Applications International Corporation (SAIC) carries a lower debt/equity ratio of 14% versus 128% for DLH Holdings Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — DLHC or CRAI or ICFI or LDOS or SAIC?
By revenue growth (latest reported year), CRA International, Inc.
(CRAI) is pulling ahead at 9. 3% versus -13. 0% for DLH Holdings Corp. (DLHC). On earnings-per-share growth, the picture is similar: CRA International, Inc. grew EPS 20. 8% year-over-year, compared to -81. 5% for DLH Holdings Corp.. Over a 3-year CAGR, CRAI leads at 8. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DLHC or CRAI or ICFI or LDOS or SAIC?
Leidos Holdings, Inc.
(LDOS) is the more profitable company, earning 8. 5% net margin versus 0. 4% for DLH Holdings Corp. — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LDOS leads at 12. 3% versus 4. 9% for DLHC. At the gross margin level — before operating expenses — ICFI leads at 34. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DLHC or CRAI or ICFI or LDOS or SAIC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Leidos Holdings, Inc. (LDOS) is the more undervalued stock at a PEG of 0. 54x versus ICF International, Inc. 's 0. 92x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Science Applications International Corporation (SAIC) trades at 9. 3x forward P/E versus 16. 9x for CRA International, Inc. — 7. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LDOS: 55. 5% to $204. 00.
08Which pays a better dividend — DLHC or CRAI or ICFI or LDOS or SAIC?
In this comparison, SAIC (1.
6% yield), CRAI (1. 5% yield), LDOS (1. 2% yield), ICFI (0. 8% yield) pay a dividend. DLHC does not pay a meaningful dividend and should not be held primarily for income.
09Is DLHC or CRAI or ICFI or LDOS or SAIC better for a retirement portfolio?
For long-horizon retirement investors, Science Applications International Corporation (SAIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
26), 1. 6% yield, +104. 4% 10Y return). Both have compounded well over 10 years (SAIC: +104. 4%, DLHC: +24. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DLHC and CRAI and ICFI and LDOS and SAIC?
These companies operate in different sectors (DLHC (Unknown) and CRAI (Industrials) and ICFI (Industrials) and LDOS (Technology) and SAIC (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: DLHC is a small-cap quality compounder stock; CRAI is a small-cap deep-value stock; ICFI is a small-cap deep-value stock; LDOS is a mid-cap deep-value stock; SAIC is a small-cap deep-value stock. CRAI, ICFI, LDOS, SAIC pay a dividend while DLHC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.